Lexeo Therapeutics names new chief medical officer Jan 27, 2026 07:30AM
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics Jan 27, 2026 07:30AM
Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights Aug 14, 2025 07:30AM
Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics Jun 24, 2025 07:30AM